What is Waters Corporation's biosciences — goodwill?

Waters Corporation (WAT) reported biosciences — goodwill of $3.80B in Q1 2026.

What does biosciences — goodwill mean?

The accumulated premium paid for past acquisitions within the Biosciences business segment that exceeds the fair value of the acquired tangible and intangible assets.

Business Segments · Goodwill

Biosciences — Goodwill

Analysis

StatementSegment

CategoryCapital Allocation

SignalContext dependent

VolatilityStable

First reportedQ1 2026

Last reportedQ1 2026

Rolls up toGoodwill

How to read this metric

An increase typically indicates recent acquisition activity within the segment, while a decrease may signal impairment charges or divestitures. Significant changes often reflect management's strategy regarding inorganic growth and the perceived future earnings potential of the Biosciences unit.

Detailed definition

This represents the excess of the purchase price over the fair value of identifiable net assets acquired in business com...

Peer comparison

Peer companies in the analytical instrument and life sciences tools sector typically report goodwill by segment, with levels varying based on the frequency and scale of M&A activity.

Metric ID: wat_segment_biosciences_goodwill

Historical Data

1 periods

	Q1 '26
Value	$3.80B

Similar Metrics at Other Companies

Agilent TechnologiesA View metric

GLW

CorningGLW View metric

GLW

CorningGLW View metric

Agilent TechnologiesA View metric

PfizerPFE View metric

Frequently Asked Questions

What is Waters Corporation's biosciences — goodwill?: Waters Corporation (WAT) reported biosciences — goodwill of $3.80B in Q1 2026.
What does biosciences — goodwill mean?: The accumulated premium paid for past acquisitions within the Biosciences business segment that exceeds the fair value of the acquired tangible and intangible assets.